⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16424463 | 1.00 | ALDH1A1 (0.36) | — | |
| Ammonia Solution, Strong SCHEMBL10792221 | 0.96 | ALDH1A1 (0.33) | — | |
| SCHEMBL17376007 | 0.86 | L3MBTL1 (0.32) | — | |
| SCHEMBL9614017 | 0.86 | L3MBTL1 (0.32) | — | |
| SCHEMBL17691527 | 0.86 | — | — | |
| SCHEMBL17691528 | 0.86 | — | — | |
| SCHEMBL17376021 | 0.83 | L3MBTL1 (0.31) | — | |
| SCHEMBL80816 | 0.83 | L3MBTL1 (0.31) | — | |
| SCHEMBL17376013 | 0.83 | L3MBTL1 (0.31) | — | |
| SCHEMBL17719302 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630677-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20240294712-A1 | RESIN SUITABLE FOR THREE-DIMENSIONAL PRINTING | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-09-05 | — | — | US | disclosed |
| US-12006401-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| CN-117794373-A | Antibacterial/antiviral agent composition, antibacterial/antiviral structure, and method for producing antibacterial/antiviral structure | 日华化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| EP-3157971-B1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2023-08-09 | — | — | EP | disclosed |
| WO-2023013687-A1 | ANTIBACTERIAL/ANTIVIRAL AGENT COMPOSITION, ANTIBACTERIAL/ANTIVIRAL STRUCTURE, AND ANTIBACTERIAL/ANTIVIRAL STRUCTURE PRODUCTION METHOD | 日華化学株式会社 | 2023-02-09 | — | — | WO | disclosed |
| US-20220325049-A1 | RESIN SUITABLE FOR THREE-DIMENSIONAL PRINTING | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2022-10-13 | — | — | US | disclosed |
| US-20170158803-A1 | URETHANE ACRYLIC POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2017-06-08 | — | — | US | disclosed |
| EP-3157971-A1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | Arkema France (FR) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015198493-A1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2015-12-30 | — | — | WO | disclosed |
| US-20120071486-A1 | THIENOPYRIMIDINE COMPOUNDS AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |
| US-8058280-B2 | Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-11-15 | — | — | US | disclosed |
| US-20080108623-A1 | N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7300935-B2 | Thienopyrimidine compounds and use thereof | TAKEDA PHARMACEUTICAL COMPANY (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20060160829-A1 | N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1591446-A1 | THIENOPYRIMIDINE COMPOUNDS AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2005-11-02 | — | — | EP | disclosed |
| EP-0565826-B1 | Process for the preparation of substituted or unsubstituted chloromethylcyclopropane or bromomethylcyclopropane | HUELS CHEMISCHE WERKE AG (DE) | 1996-04-24 | — | — | EP | disclosed |
| EP-0565826-A1 | Process for the preparation of substituted or unsubstituted chloromethylcyclopropane or bromomethylcyclopropane | HÜLS AKTIENGESELLSCHAFT (DE) | 1993-10-20 | — | — | EP | disclosed |
| EP-0244129-B1 | OPTICALLY ACTIVE COMPOUND AND LIQUID CRYSTALLINE COMPOSITION | AJINOMOTO CO., INC. (JP) | 1992-11-11 | — | — | EP | disclosed |
| US-4880561-A | Optically active compound and liquid crystalline composition | AJINOMOTO CO., INC. (JP) | 1989-11-14 | — | — | US | disclosed |